The TIKR Blog
Sharing actionable investing insights, in-depth stock analysis, and expert tips to help you make smarter investment decisions and think like a business owner.
Latest Posts
Discover our most recent fundamental investing insights.
Here’s Why RH Stock Could Gain 38% After Falling 74% From Its All-Time Highs
The 2-Minute Valuation Model values RH stock at $260/share in 2 years. That’s a potential 38% upside from today’s price of $189/share.
Nvidia is Up 28,650% in the Past Decade. Is NVDA Stock Still a Good Buy?
Nvidia has generated market-beating returns to shareholders in the past decade. Can NVDA stock continue to outperform?
Marvell Stock Surges 7% After AI Event Shows a Robust Growth Pipeline
Here’s why analysts are bullish on Marvell stock following its recent AI event. Is MRVL a good buy right now?
Chipotle Mexican Grill Is Down 24% From All-Time Highs. Is Now a Good Time to Buy CMG Stock?
Chipotle is a fast-food giant wrestling with slower consumer spending in 2025. Is CMG a good stock to own right now?
Lululemon Is Down 54% From All-Time Highs. Can LULU Stock Finally Recover In 2025?
Lululemon stock is down 54% from all-time highs in June 2025. Can LULU stock recover and deliver outsized gains to shareholders?
Why Alcoa Stock Could Have 33% Upside Today
The 2-Minute Valuation Model values Alcoa stock at $40/share in 2 years. That’s a potential 38% upside from today’s price of $29/share.
CAVA Is Down 57% From All-Time Highs. Can the Restaurant Stock Recover?
Down 57% from all-time highs, CAVA is a restaurant stock that remains expensive. Can it rebound in the second half of 2025?
Is Chevron (CVX) Stock Overvalued Despite its 4.4% Dividend Yield?
The 2-Minute Valuation Model values CVX stock at $163/share in 2 years. That’s a potential 9% upside from today’s price of $149/share.
First Solar (FSLR) Stock Tanks 18% As Tax Bill Targets Clean Energy Credits
First Solar (FSLR) stock just slumped almost 18% after the latest tax bill proposal targets clean energy credits.
Verve Therapeutics Stock Surges 81% As Eli Lilly Acquires the Gene-Editing Firm
Verve Therapeutics stock rallied by 81% in a single trading session after Eli Lilly announced plans to acquire the gene-editing company.
Roku Stock Gains Over 10% On Amazon Ads Partnership
Roku stock surged more than 10% yesterday after it announced a partnership with Amazon Ads. The tech stock has now increased by 50% over the past year.
Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.